Altnvest
LibraryNexPoint Life Sciences III DST
Back to Offering

Transaction Metrics

Processed

NexPoint Life Sciences III DST

The asset was acquired for $57,750,000 against an appraised value of $59,000,000. Total acquisition cost with reserves is $59,094,426 at a 5.83% cap rate.

Valuation ladder

Acquisition price$57.75M
Offering price$61.96M+7.3%
Appraised value$230.0% of offering

Cap rate spread & load

Acquisition cap rate5.83%
Syndicated cap rate5.83%

0 bps of spread between acquisition and syndicated cap rate.

Upfront load on offering4.63%
Load on equity9.35%
Acquisition Price

$57,750,000

Offering Price

$61,961,253

Appraised Value

An appraisal dated October 23, 2023 reflects an "as is" market value for the Property of $59,000,000, but no acquisition cap rate or going-in yield is stated in the excerpts provided.

Upfront Load

Load on Equity

Load on Offering Price

Acquisition Cap Rate

5.83%

Syndicated Cap Rate

5.83%

Premium / Discount

Appraisal / Offering %

95.37%

Less Reserves %

Strengths

  • Acquisition price of $57,750,000 is below appraised value of $59,000,000.
  • Going-in cap rate of 5.83% matches syndicated cap rate.

Concerns

  • Total acquisition cost reaches $59,094,426 after reserves and expenses.
  • Appraisal does not disclose independent market going-in cap rate.